The fibrinolytic response to venous occlusion and the natural anticoagulants in patients with antiphospholipid antibodies both with and without systemic lupus erythematosus
- 12 March 1991
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 77 (3) , 354-359
- https://doi.org/10.1111/j.1365-2141.1991.tb08583.x
Abstract
Summary: Patients with systemic lupus erythematosus (SLE) have an increased risk of thrombosis and this is increased in the presence of antiphospholipid antibodies (APA). These APA are also associated with thrombosis in patients who do not have SLE. We compared haemostatic parameters in SLE patients with and without APA, and also compared patients who had APA but not SLE with healthy normal controls. No relationships between the natural anticoagulants. anti‐thrombin III, heparin cofactor II, protein C and protein s. and the presence of APA were found. In the patients with SLE both tissue plasminogen activator antigen and plasminogen activator inhibitor (PAI) were increased, but these changes were not due to APA which had no effect on fibrinolysis in these patients. In the patients with APA who did not have SLE the fibrinolytic response to venous occlusion was reduced due to raised levels of PAI; similar changes have, however, been reported in some patients with idiopathic thrombosis.Keywords
This publication has 28 references indexed in Scilit:
- Tissue plasminogen activator inhibitor in patients with systemic lupus erythematosus and thrombosis.BMJ, 1990
- Anticardiolipin antibodies in HIV-negative and HIV-positive haemophiliacsBlood Coagulation & Fibrinolysis, 1990
- The “Primary” Antiphospholipid SyndromeMedicine, 1989
- Indications of vascular endothelial cell dysfunction in systemic lupus erythematosus.Annals of the Rheumatic Diseases, 1987
- Anticardiolipin antibodies: isotype distribution and phospholipid specificity.Annals of the Rheumatic Diseases, 1987
- Circulating Anticoagulant in Systemic Lupus erythematosus: Clinical ManifestationsActa Haematologica, 1986
- Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor.BMJ, 1985
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982
- Low functional and high antigenic antithrombin iii level in a patient with the lupus anticoagulant and recurrent thrombosisArthritis & Rheumatism, 1981
- Gerinnungsphysiologische Schnellmethode zur Bestimmung des FibrinogensActa Haematologica, 1957